ANRO US Equity

Alto Neuroscience, Inc.

Health Care · Pharmaceutical Preparations · CIK 1999480 · FY ends Dec 31

$34.89

+0.76 (+2.23%)

USD · as of 2026-08-19 · marketstack

Switch Ticker

Documents

3 of 3 10-Ks readable here

Period end	Filed	Form	Read here	EDGAR
2025-12-31	2026-03-16	10-K	read · risk factors · MD&A	index · original · 0001999480-26-000002
2024-12-31	2025-03-20	10-K	read · risk factors · MD&A	index · original · 0001999480-25-000025
2023-12-31	2024-03-21	10-K	read · risk factors · MD&A	index · original · 0001999480-24-000010

78 captions · 3 filings

Descriptive and within-name: this is what changed in the wording of one firm's own filings.

78 captions across 3 filings10 added10 dropped58 in every year3 of 3 10-Ks on file are cached here

Risk-factor caption

2023

2024

2025

Years

●

3 rw

●

3 rw

●

3 rw

●

The filer's own 10-K text · 3 filings read

Rows are the filing's own headings, verbatim — nothing is summarized or generated.

A blank cell means the filer did not print that heading that year — not that the risk ended.

Gates: 5+ captions · 50% of Item 1A · match at Jaccard 0.6.

3 filings measured

Descriptive and within-name: this is what changed in the wording of one firm's own filings.

Filed	Period end	Document words	Item 1A words	Negation / 10k	Hedging / 10k	Filing
2024-03-21	2023-12-31	131,399	53,291	64.76	178.69	read · EDGAR ↗
2025-03-20	2024-12-31	111,105	55,559	71.19	197.02	read · EDGAR ↗
2026-03-16	2025-12-31	118,288	57,503	69.49	194.02	read · EDGAR ↗

The filer's own 10-K text · 3 filings measured

House wordlists, not a licensed dictionary and not tuned against returns.

9 negation words · 40 hedging words — hover to read both lists.

Each point sits at its filing date and is held flat until the next filing.